Personalized Functional Profiling in Metastatic Gastrointestinal Cancer or Recurrent Glioblastoma Patients in Luxembourg.

NACompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

March 11, 2019

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Oncology
Interventions
DIAGNOSTIC_TEST

Personalized Functional Profiling

During this pilot study, the overall goal of the project is to establish an effective workflow between the patient, the PFP platform, the clinician and return to the patient. This includes collection of the biopsy or surgery piece and standardized processing, dissociation, drug profiling and issuing treatment recommendation to the clinician. In case the clinician follows this treatment recommendation, patient management and follow up will be performed according to standard of care.

Trial Locations (2)

1210

Centre hospitalier de Luxembourg, Luxembourg

2540

Hôpitaux Robert Schmuan, Luxembourg

All Listed Sponsors
collaborator

Integrated Biobank of Luxembourg

OTHER

collaborator

Laboratoire National de Santé (Luxembourg)

UNKNOWN

collaborator

Centre Hospitalier du Luxembourg

OTHER

collaborator

Hopitaux Robert Schuman (Luxembourg)

UNKNOWN

lead

Luxembourg Institute of Health

OTHER_GOV

NCT03997617 - Personalized Functional Profiling in Metastatic Gastrointestinal Cancer or Recurrent Glioblastoma Patients in Luxembourg. | Biotech Hunter | Biotech Hunter